Investing
Top 10 Analyst Upgrades & Downgrades (ATK, CELG, NTAP, NVLS, WMT, ATHN, ARNA, BK, GENZ, Q)
Published:
These are the top 10 analyst upgrades, downgrades, and initiations we have seen early this Monday morning:
Alliant Techsystems (ATK) Started as Buy at Jefferies.
Celgene (CELG) raised to Outperform at R.W.Baird.
NetApp (NTAP) raised to Conviction Buy List at Goldman Sachs
Novellus (NVLS) Raised to Outperform at Credit Suisse.
Wal-Mart (WMT) Started as Overweight at HSBC.
Athenahealth (ATHN) started as Sell at Citigroup.
Arena Pharmaceuticals (ARNA) cut to Market Perform at Leerink Swann.
Bank of New York Mellon (BK) Cut to Neutral at Goldman Sachs.
Genzyme (GENZ) Cut to Perform at Oppenheimer.
Qwest (Q) Cut to Conviction Sell List, but was already a Sell, at Goldman Sachs.
JON C. OGG
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
